Skip to main content
SpringerLink
Log in

Bullous pemphigoid in patients with DPP-4 inhibitors at the onset of disease: does this differ from common bullous pemphigoid?

  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. MendonÇa FM, Martín–Gutierrez FJ, Ríos–Martín JJ, Camacho–Martinez F. Three cases of bullous pemphigoid associated with dipeptidyl peptidase–4 inhibitors–one due to linagliptin. Dermatology 2016; 232: 249–53.

    Article  CAS  PubMed  Google Scholar 

  2. Skandalis K, Spirova M, Gaitanis G, Tsartsarakis A, Bassukas ID. Drug–induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase–IV inhibitors plus metformin. J Eur Acad Dermatol Venereol 2012; 26: 249–53.

    Article  CAS  PubMed  Google Scholar 

  3. Pasmatzi E, Monastirli A, Habeos J, Georgiou S, Tsambaos D. Dipeptidyl peptidase–4 inhibitors cause bullous pemphigoid in diabetic patients: report of two cases. Diabetes Care 2011; 34: e133.

    Article  Google Scholar 

  4. Attaway A, Mersfelder TL, Vaishnav S, Baker JK. Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature. J Dermatol Case Rep 2014; 8: 24–8.

    PubMed  Google Scholar 

  5. García M, Aranburu MA, Palacios–Zabalza I, Lertxundi U, Aguirre C. Dipeptidyl peptidase–IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database. J Clin Pharm Ther 2016; 41: 368–70.

    Article  PubMed  Google Scholar 

  6. Haber R, Fayad AM, Stephan F, Obeid G, Tomb R. Bullous pemphigoid associated with linagliptin treatment. JAMA Dermatol 2016; 152: 224–6.

    Article  PubMed  Google Scholar 

  7. Izumi K, Nishie W, Mai Y, et al. Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid. J Invest Dermatol 2016; 136: 2201–10.

    Article  CAS  PubMed  Google Scholar 

  8. Fania L, Salemme A, Provini A, et al. Detection and characterization of IgG, IgE and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase–IV inhibitors. J Am Acad Dermatol 2018; 78: 592–5.

    Article  PubMed  Google Scholar 

  9. Béné J, Moulis G, Bennani I, et al. Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case–noncase study in the French Pharmacovigilance Database. Br J Dermatol 2016; 175: 296–301.

    Article  CAS  PubMed  Google Scholar 

  10. Schaffer C, Buclin T, Jornayvaz FR, et al. Use of dipeptidylpeptidase IV inhibitors and bullous pemphigoid. Dermatology 2017; 233: 401–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Autoimmune Bullous Diseases Outpatient Clinic, 2nd Department of Dermatology, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece

    Aikaterini Patsatsi, Aikaterini Kyriakou, Parthena Meltzanidou, Anastasia Trigoni, Foteini Lamprou & Miltiadis Kokolios

  2. Laboratory of Immunology, Papageorgiou General Hospital, Thessaloniki, Greece

    Anastasia Giannakou

Authors
  1. Aikaterini Patsatsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aikaterini Kyriakou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Parthena Meltzanidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anastasia Trigoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Foteini Lamprou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Miltiadis Kokolios
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anastasia Giannakou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aikaterini Patsatsi.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patsatsi, A., Kyriakou, A., Meltzanidou, P. et al. Bullous pemphigoid in patients with DPP-4 inhibitors at the onset of disease: does this differ from common bullous pemphigoid?. Eur J Dermatol 28, 711–713 (2018). https://doi.org/10.1684/ejd.2018.3371

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3371

Search

Navigation